Atrial Fibrillation Research

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Chris Cannon, MD, FACC, discusses 3 research papers on atrial fibrillation in this video produced by the American College of Cardiology.

Related Articles
Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure.
Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin.
Andexanet alfa showed promise as an anti-Xa reversal agent in new research presented at the American Heart Association's Scientific Session 2014.
Is moderation the key to all things, including exercise?
Latest Issues
$auto_registration$